Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

SCIENION’s sciFLEXARRAYER Used for the Production of Anagnostics’ Integrated Sepsis Testing Products

Published: Monday, April 22, 2013
Last Updated: Sunday, April 21, 2013
Bookmark and Share
Minimum hands-on time, simple usage and fast and comprehensive results.

SCIENION AG and Anagnostics Bioanalysis GmbH have announced that Anagnostics is using Scienion’s sciFLEXARRAYER for the production of Anagnostics new product line focusing on integrated sepsis testing, based on DNA and protein based multiplex assays.

Anagnostics is specialized in developing systems and tests for multiplex diagnostics and has developed its proprietary hybcell technology.

Anagnostics' hybcell is the world's first DNA or protein microarray based on the use of cylinders instead of slides. The microarray is spotted on the outside of a cylinder, fitting in a hollow cylinder, serving as sample container.

These hybcells are automatically processed by the laboratory device - the hyborgs, Anagnostics’ fully integrated and automated single device system for multiplexed diagnostics.

Minimum hands-on time, simple usage and fast and comprehensive results make this system perfectly suitable for (clinical) routine diagnostics.

Especially in sepsis diagnostics a fast and reliable technology is needed in clinics. The complexity of the disease demands comprehensive answers which only multiplexed technologies can deliver in due time.

“The sciFLEXARRAYER proved to be the best dispensing device to print our hybcells, be it for DNA or protein based tests”, says Christoph Reschreiter, CEO of Anagnostics Bioanalysis GmbH.

Reschreiter continued, “We produce ready to use microarrays for our customers and precision and reproducibility have been key criteria when we decided to work with this Scienion dispenser.”

For printing the cylindrical microarrays Anagnostics has developed a spotting adapter. hybcells have been developed for drugs of abuse screening, companion diagnostics and for integrated sepsis testing.

Integrated sepsis testing combines the concept of molecular pathogen and resistances detection based on DNA with the monitoring of a panel of inflammation markers to survey the patient’s immune status.

Holger Eickhoff, CEO of SCIENION AG, comments: “We have experienced Anagnostics as a very reliable partner with excellent people and a superb technology. Facing a dynamic development of next generation diagnostic products, Anagnostics with its novel hybcell technology does make an obvious contribution in this development. We are very pleased that hybcells are being produced with our sciFLEXARRAYER and once more we have demonstrated the versatility of our devices. Scienion enables the dispensing of any kind of content to any kind of surface such as these novel cylindrical microarrays.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Detection of Colon Cancer
AIT, BioVendor and SCIENION signed cooperation agreement for early detection of colon cancer.
Saturday, September 27, 2014
Scientific News
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Horse Illness Shares Signs of Human Disease
Horses with a rare nerve condition have similar signs of disease as people with conditions such as Alzheimer’s, a study has found.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
The Age of Humans Controlling Microbes
Engineered bacteria could soon be used to detect environmental toxins, treat diseases, and sustainably produce chemicals and fuels.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
New Test Detects All Viruses
A new test detects virtually any virus that infects people and animals, according to research at Washington University School of Medicine in St. Louis, where the technology was developed.
Scientists Create World’s Largest Catalog of Human Genomic Variation
An international team of scientists from the 1000 Genomes Project Consortium has created the world’s largest catalog of genomic differences among humans, providing researchers with powerful clues to help them establish why some people are susceptible to various diseases.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos